PMC:7600245 / 32956-33051 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T120","span":{"begin":74,"end":82},"obj":"Disease"},{"id":"T121","span":{"begin":85,"end":94},"obj":"Disease"}],"attributes":[{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Darunavir/cobicistat is under clinical investigation for the treatment of SARS-CoV-2 infection."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T491","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"T492","span":{"begin":10,"end":20},"obj":"Chemical"}],"attributes":[{"id":"A491","pred":"chebi_id","subj":"T491","obj":"http://purl.obolibrary.org/obo/CHEBI_367163"},{"id":"A492","pred":"chebi_id","subj":"T492","obj":"http://purl.obolibrary.org/obo/CHEBI_72291"}],"text":"Darunavir/cobicistat is under clinical investigation for the treatment of SARS-CoV-2 infection."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T240","span":{"begin":0,"end":95},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Darunavir/cobicistat is under clinical investigation for the treatment of SARS-CoV-2 infection."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"970","span":{"begin":0,"end":20},"obj":"Chemical"},{"id":"984","span":{"begin":74,"end":94},"obj":"Disease"}],"attributes":[{"id":"A984","pred":"tao:has_database_id","subj":"984","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Darunavir/cobicistat is under clinical investigation for the treatment of SARS-CoV-2 infection."}